118 Best Bone Marrow Transplantation Doctors Abroad

Founder of the Bone Marrow Transplantation Center at Anadolu – Prof. Gulbas is ranked as Turkey's No. 1 hematologist-oncologist.

• Specializes exclusively in bone marrow transplantation
• Trained at top centers including Fred Hutchinson in Seattle
• Director of medical oncology since 2005
• Member of Türk Hematoloji Derneği (Turkish Society of Hematology)

Prof. Tavil specializes in pediatric bone marrow transplants, with 100+ successful stem cell procedures at Memorial Şişli Hospital.

• 29 years focused on pediatric hematology and oncology
• Treated 500+ children with leukemia
• Published 147 papers on childhood blood disorders with 1,700+ citations
• Expert in rare genetic blood disease treatments
• Awarded by Turkish Hematology Society for pediatric cancer care

Dr. Hana Golan heads the Pediatric Hemato-Oncology and Bone Marrow Transplantation Division at Sheba Medical Center. She specializes in high-risk pediatric tumors and complex childhood cancers. Dr. Golan serves as the principal investigator for the High-Risk Neuroblastoma ESIOP protocol. She practices at a hospital ranked among the global top 10 by Newsweek.

• National coordinator of multicenter oncology protocols and international Phase I/II clinical trials.
• Performs bone marrow transplants and CAR T-cell therapy for pediatric patients.
• Expert in neuroblastoma, leukemia, and treatment-resistant malignancies.
• Senior Lecturer at the Sackler Faculty of Medicine at Tel Aviv University.

Dr. Luis Madero is the Head of Pediatric Hemato-Oncology at Quironsalud Madrid University Hospital. He specializes in treating complex blood disorders and performing bone marrow transplants. Dr. Madero serves as a Professor of Pediatrics at the Autonomous University of Madrid. He works at Quironsalud Madrid, which Newsweek ranked among the World's Best Hospitals.

• Edited 14 books and contributed to 75 book chapters on pediatric oncology.
• Treats leukemia, lymphoma, multiple myeloma, and sickle cell disease.
• Member of the Spanish Association of Pediatric Hematology and Oncology.
• Former Head of Oncology at the Sanitas Group and Nino Jesus Hospital.

Trained at Mayo Clinic and with 18 international publications – Dr. Sevindik brings extensive hematology expertise to Istanbul Florence Nightingale Hospital.

• Specializes in hematology and internal medicine
• Worked at Bağcılar Medipol University Hospital for 12 years
• 18 articles published in international peer-reviewed journals
• 26 abstracts presented at international conferences

Professor Bulent Eser specializes in bone marrow transplantation at Medical Park Antalya Hospital Complex, with over 36 years of hematology expertise.

• Member of the European Group for Blood and Marrow Transplantation
• Professor of Internal Medicine/Hematology at Erciyes University
• Extensive research and academic background in hematology
• Part of the Turkish Society of Hematology

Dr. Arnon Nagler is a hematologist at Sheba Medical Center in Israel. He is a professor at Tel Aviv University and a renowned transplant expert. Dr. Nagler founded Israel’s first public cord blood bank. He also performed the first cord blood transplantations in the country. He completed postdoctoral training at Stanford University and is board-certified in hematology.

• Pioneered reduced–intensity allogeneic transplant protocols for blood cancers.
• Served as Chair of the Acute Leukemia Working Party for the EBMT.
• Published over 400 articles in leading journals like Blood and Leukemia.
• Works at Sheba Medical Center, ranked 7th worldwide by Newsweek in 2026.

Dr. Ram Ron specializes in bone marrow transplantation with extensive experience at Sourasky Medical Center.

• Over 24 years of experience in medical treatments
• Specializes in Obstetrics & Gynecology Reproduction Medicine
• Fellowship from Ronald O Perelman and Claudia Cohen Centre

Dr. Ron Ram has performed several hundred stem cell transplants and is board-certified in Internal Medicine, Hematology, and Medical Oncology at Sourasky Medical Center.

• Completed fellowship in Hematology and Oncology at New York Medical College
• Published over 30 scientific articles on hematology and oncology
• Authored a chapter in a medical textbook
• Extensive academic and clinical experience in bone marrow transplantation

Over 300 bone marrow and umbilical blood transplantations – Dr. El Hasid leads pediatric transplant care at Dana Dwek Children’s Hospital.

• Head of Pediatric Oncohematology and Oncology at Sourasky Medical Center
• Member of American Association for Hematology
• Trained at City of Hope Hospital in Los Angeles
• Published 50 research papers on transplantation

Dr. Amos Toren is a pediatric hemato-oncologist at Sheba Medical Center. He served as Director of the Pediatric Hemato-Oncology and Bone Marrow Transplant Division. Dr. Toren holds a PhD in Human Genetics. He specializes in CAR T-cell therapy and bone marrow transplantation for children. Forbes Israel has recognized his expertise in hematology.

• Served as the Head of the Hematology Division at Tel Aviv University.
• Treats complex cases of leukemia, lymphoma, and rare pediatric cancers.
• Member of the American Society of Hematology and European Group for Blood and Marrow Transplantation.
• Collaborates on research with the NIH and St. Jude Children’s Research Hospital.

Chief physician and professor. Grade 1 Expert at the Cancer Center, West China Hospital, Sichuan University (ranked No. 2 in China). Completed a postdoctoral fellowship in interventional radiology at the Chinese PLA General Hospital. Leads multidisciplinary team (MDT) care for complex tumors. Expert in minimally invasive interventional oncology for liver, lung, and pancreatic cancers.

Accreditations: Council Member, WATA. Member of CACA and CMDA committees on intervention, ablation, radioactive seeds, and pain. In 2023, inaugural director member, Palliative Care Committee, Sichuan MDA. Editorial board member of the Chinese Journal of Interventional Imaging and Therapy. Editorial board member of the Chinese Journal of Pain Medicine.

Leads 2 provincial S&T projects and 2 NSFC projects. Has 40+ papers, with 30+ as first or corresponding author. Highest impact factor: 10.73. Hepatocellular carcinoma (HCC) cohort: TACE + lenvatinib vs TACE + sorafenib. OS 18.97 vs 10.77 months. PFS 10.6 vs 5.4 months. ORR 66.8% vs 33.3%.

Dr. Ahmet Demir specializes in pediatric bone marrow transplants with focused on leukemia and Hodgkin lymphoma. His research is internationally recognized.

• Specialized in Pediatric Oncology at Hacettepe University
• Associate Professor in 'Health and Diseases of Children'
• Member of the Society of International Pediatric Oncology
• Performs bone marrow transplants at Memorial Ankara Hospital

Prof. Bozkurt specializes in pediatric bone marrow transplants, with training at Cincinnati Children's Hospital and leadership at Medical Park Bahcelievler.

• Trained in pediatric oncology at Dr. Sami Ulus Children’s Hospital
• Vice Director of the Stem Cell Transplant Unit
• Member of the European Bone Marrow Transplant Group
• Published 40+ peer-reviewed articles on pediatric hematology

Professor Fabio Ciceri leads San Raffaele's Bone Marrow Transplantation Unit, pioneering cell and gene therapy trials for hematologic cancers.

• Head of Hematology and Bone Marrow Transplantation at San Raffaele Research Hospital
• Principal Investigator in clinical trials for hematologic cancers and immune-deficiencies
• Published over 180 research papers in hematology
• Member of the European Blood and Marrow Transplantation Group

Professor Luo Xiaoping is a nationally recognized interventional radiologist and a leading authority in Western China. He began pioneering vascular interventions in the early 1990s. He helped found the Interventional Group at the Second Affiliated Hospital of Chongqing Medical University.

He has completed over 100,000 interventional procedures, including about 4,000 complex cases. His key skills include TACE for hepatocellular carcinoma, Budd–Chiari interventions, TIPS, and single-stage bilateral stenting for hilar biliary obstruction, with success rates near 100%. He has been a master’s supervisor since 2007. He has trained many physicians, guided complex cases at more than 40 major hospitals across Western China, and helped build interventional programs. He has published 32 papers as first or corresponding author (22 CSCD core, 4 Chinese core, 6 CSCD extended).

Dr. He Weibing is a pioneer of argon-helium cryoablation in China with more than 20 years of frontline practice. He was a founding member of Fuda Cancer Hospital (Guangzhou). He co-founded its Minimally Invasive Tumor Treatment Center and served as Executive Deputy Director. He also helped found the Ablation Group of the China Anti-Cancer Association. He has been the primary operator in more than 10,000 procedures.

He specializes in tumor cryoablation and is proficient in 125I seed brachytherapy, with a focus on liver and lung cancers. He proposed ten argon-helium techniques. Key co-authored data include: lung cryotherapy n=508; NSCLC n=120 (CR 25.5%, PR 41.8%, 6/12/24-month survival 64%/55%/36%); pancreatic cancer n=38 (median survival 12 months). He served on editorial boards in 2008 and 2010. He has been a national trainer for Varian and Boston Scientific since 2001.

Head of Italy's largest bone marrow transplant program, performing 90+ allogeneic transplants yearly at San Raffaele. One of the country's top lymphoma specialists.

• Leads the Bone Marrow Transplant Unit since 2006
• Specialized in haematology and internal medicine from University of Milan
• Published 70+ studies on transplantation and blood cancers
• Member of European Society for Blood and Marrow Transplantation

Dr. Ding Yi is the Associate Chief Physician in Hematology at Shanghai Tongji Hospital. She is also the acting deputy director of the Blood Transfusion Department. She holds a Master of Medicine from Tongji University. She serves on the Youth Committee of the Shanghai Society of Hematology.

She is skilled in diagnosing and treating leukemia, lymphoma, and myeloma. She offers hematopoietic and umbilical cord blood stem cell therapies. She specializes in acute leukemia. She developed sequential treatment protocols. She participated in research that won the Second Prize of the Shanghai Science and Technology Progress Award. She has published more than 10 papers.